Neovasc Named Finalist in Questex’s Fierce Innovation Awards LifeSciences Edition 2019
VANCOUVER, Dec. 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN): NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement …